Quick Answer
Jaguar Health, Inc. reported Total Revenue of $11.69 million for the year ending 2024.
- Jaguar Health, Inc. showed an increase of +19.8% in Total Revenue from 2023 to 2024.
- This data is from Jaguar Health, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2016 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2016: $38.1 thousand | Q2 2016: $24.1 thousand | Q3 2016: $50.4 thousand | Q1 2017: $822.4 thousand | Q2 2017: $896.5 thousand | Q3 2017: $1.10 million | Q1 2018: $804.4 thousand | Q2 2018: $883.8 thousand | Q3 2018: $1.13 million | Q1 2019: $1.59 million | Q2 2019: $1.71 million | Q3 2019: $973.0 thousand | Q1 2020: $869.0 thousand | Q2 2020: $3.17 million | Q3 2020: $2.77 million | Q3 2023: $2.81 million | Q1 2024: $2.35 million | Q2 2024: $2.72 million | Q3 2024: $3.11 million | Q1 2025: $2.21 million | Q2 2025: $2.98 million | Q3 2025: $3.08 million.
- Over the full 9 years of available data (2016 to 2024), Jaguar Health, Inc.'s Total Revenue has grown by 8,159.4%.
- Historical annual values: Fiscal year 2024: $11.69 million | Fiscal year 2023: $9.76 million | Fiscal year 2022: $11.96 million | Fiscal year 2021: $4.34 million | Fiscal year 2020: $9.39 million | Fiscal year 2019: $5.78 million | Fiscal year 2018: $4.42 million | Fiscal year 2017: $4.36 million | Fiscal year 2016: $141.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: